A Normotriglyceridemic, Low HDL-cholesterol Phenotype is Characterised by Elevated Oxidative Stress and HDL Particles with Attenuated Antioxidative Activity
Overview
Affiliations
Objective: Low levels of high density lipoprotein-cholesterol (HDL-C) are highly prevalent in subjects presenting premature atherosclerosis. It is indeterminate as to whether high cardiovascular risk in low HDL-C subjects occurs concomitantly with elevated oxidative stress and/or with biologically dysfunctional HDL particles.
Methods And Results: Systemic oxidative stress (as plasma 8-isoprostanes) was 2.3-fold elevated (p<0.05) in normocholesterolemic, normotriglyceridemic, normoglycemic low HDL-C subjects (plasma HDL-C, <40 mg/dL; n=8) as compared to normolipidemic controls (n=15). HDL subfractions (HDL2b, 2a, 3a, 3b and 3c) isolated by density gradient ultracentrifugation from low HDL-C subjects displayed significantly lower (-21 to -43%, p<0.05) specific antioxidative activity (sAA; capacity to protect LDL from oxidation on a unit particle mass or on a particle number basis) as compared to controls. Altered chemical composition (core triglyceride enrichment, cholesteryl ester depletion) paralleled antioxidative dysfunction of HDL subfractions. Plasma 8-isoprostane levels negatively correlated with sAA of HDL subfractions and positively correlated with the total cholesterol/HDL-C ratio, which was significantly elevated in the low HDL-C phenotype.
Conclusions: Low HDL-C subjects display elevated oxidative stress and possess HDL particle subspecies with attenuated intrinsic antioxidative activity which is intimately related to their altered chemical composition.
Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis.
Zhang Q, Zhao Y, Li L, Fan Q, Huang B, Du H J Inflamm Res. 2025; 18:1207-1233.
PMID: 39886385 PMC: 11780177. DOI: 10.2147/JIR.S499835.
The metabolic characteristics and changes of chondrocytes and in osteoarthritis.
Adam M, Zhuang H, Ren X, Zhang Y, Zhou P Front Endocrinol (Lausanne). 2024; 15:1393550.
PMID: 38854686 PMC: 11162117. DOI: 10.3389/fendo.2024.1393550.
Klobucar I, Hofmann L, Habisch H, Lechleitner M, Klobucar L, Trbusic M Antioxidants (Basel). 2024; 13(3).
PMID: 38539872 PMC: 10968302. DOI: 10.3390/antiox13030339.
Denimal D Antioxidants (Basel). 2024; 13(1).
PMID: 38247481 PMC: 10812436. DOI: 10.3390/antiox13010057.
Cholesterol in colorectal cancer: an essential but tumorigenic precursor?.
He X, Lan H, Jin K, Liu F Front Oncol. 2023; 13:1276654.
PMID: 38023258 PMC: 10655112. DOI: 10.3389/fonc.2023.1276654.